adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 732 blog entries.

13 07, 2021

Valentina Angerilli et al., Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

adlitterio663392022-10-21T09:34:56+02:00

1 07, 2021

Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling

adlitterio663392022-10-14T12:26:32+02:00

30 06, 2021

Anello Marcello Poma et al., COVID-19 autopsy cases: detection of virus in endocrine tissues

adlitterio663392022-10-21T09:41:39+02:00

24 06, 2021

Serena Ammendola et al., H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology

adlitterio663392022-10-21T13:52:43+02:00

15 06, 2021

Debora Olioso et al., Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study

adlitterio663392022-10-21T14:02:53+02:00

18 05, 2021

Anna ianza et al., EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.

adlitterio663392021-05-18T12:26:57+02:00

14 05, 2021

Alessandro Dal Maso et al., Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.

adlitterio663392022-10-21T14:06:21+02:00

10 05, 2021

Enrico Berrino et al., High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients.

adlitterio663392022-10-21T14:12:17+02:00

17 04, 2021

Yoon Ah Cho et al., Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas

adlitterio663392022-10-21T15:40:43+02:00

16 04, 2021

Michela Marina et al., Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study

adlitterio663392021-04-16T15:40:56+02:00

Vorheriges 202122 Nächstes